Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism. - Overdijk MB; Strumane K; Beurskens FJ; Ortiz Buijsse A; Vermot-Desroches C; Vuillermoz BS; Kroes T; de Jong B; Hoevenaars N; Hibbert RG; Lingnau A; Forssmann U; et al. (Molecular cancer therapeutics, 2020)